Afya Limited
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Virgilio Deloy Capobianco Gibbon
- Full Time Employees
- 5,260
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Address
- Alameda Oscar Niemeyer, No. 119 Nova Lima MG Brazil
- IPO Date
- Jul 19, 2019
- CIK
- 0001771007
- Website
- afya.com.br
- Similar Companies
- Business
- Afya Limited operates as a leading medical education group and medical practice solutions provider in Brazil. Founded in 1999 and headquartered in Nova Lima, Minas Gerais, the company offers a comprehensive portfolio of products and services organized into three main segments: Undergraduate education, Continuing Education, and Medical Practice Solutions. The Undergraduate segment comprises medical school and other health science undergraduate programs. The Continuing Education segment provides medical education including residency preparation programs, specialization test preparation, graduate courses, and other medical capabilities delivered through digital and in-person content. The Medical Practice Solutions segment offers clinical decision support, clinical management, and doctor-patient relationship solutions, mainly through brands such as Pebmed and iClinic, supporting healthcare professionals and institutions. Afya operates medical schools across various locations in Brazil, including newly expanded operations in Minas Gerais. Recent major changes include the acquisition of Faculdade Única de Contagem (FUNIC), adding 60 medical school seats with potential for an additional 60 seats contingent on Ministry of Education approval, marking expansion in Minas Gerais and strengthening Afya’s footprint as its fifth medical school in the state. The acquisition aligns with Afya’s strategic focus on growth through expanding medical education capacity and consolidating its ecosystem integrating education and medical practice solutions. Additionally, Afya restructured its continuing education segment in 2024 by consolidating various entities such as Medcel, Além da Medicina, CardioPapers, and Medical Harbour under one segment to better integrate content and technology for medical education. The company launched five new specialization campuses in 2024, reinforcing its continuing education and medical practice solutions growth strategies. Afya targets medical students, residents, physicians, and healthcare professionals across Brazil, providing an integrated ecosystem that supports the entire physician career journey. The company reported significant revenue growth and operational efficiencies with a strong focus on digital transformation and academic excellence. As of 2025, Afya has around 26,000 medical students, monthly active users of 228,000, and over 304,000 users within its ecosystem. Financially, Afya expects strong future cash flows with an enterprise value to EBITDA multiple anticipated at 3.3x by 2030 following full synergy realization from acquisitions and organic growth. Overall, Afya Limited is positioned as a dominant player in Brazil's medical education sector, combining undergraduate medical programs, advanced continuing education services, and practice management solutions to serve the healthcare education and medical practitioner markets nationwide. Their strategic expansions and restructuring efforts in recent years underscore their commitment to becoming the primary educational and professional development resource for medical professionals in Brazil.
AFYA vs. APEI: Which Stock Is the Better Value Option?
Afya Limited Releases 2025 Integrated Report
Afya Limited (the "Company") Notice of Annual General Meeting of the Company
Should Value Investors Buy Afya (AFYA) Stock?
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know
AFYA or APEI: Which Is the Better Value Stock Right Now?
Are Investors Undervaluing Afya (AFYA) Right Now?
Afya Limited (AFYA) Q1 2026 Earnings Call Transcript
Afya Limited Announces First-Quarter 2026 Financial Results
Moody's Reaffirmed Afya's AAA.br Rating With a Stable Outlook
AFYA or APEI: Which Is the Better Value Stock Right Now?
Afya Ltd (AFYA) Stock Down 4.2% -- Now Undervalued? GF Score: 88/100
Is Afya (AFYA) Stock Undervalued Right Now?
Afya (NASDAQ:AFYA) Insider Santos Welder Ferreira Sells 3,325 Shares of Stock
AFYA vs. LOPE: Which Stock Is the Better Value Option?
Afya Limited (NASDAQ:AFYA) Short Interest Update
Are Consumer Discretionary Stocks Lagging Afya (AFYA) This Year?
A Look at Afya Ltd (AFYA) After 3.9% Gain -- GF Value $20.42 vs Price $15.66
Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 770 Shares
AFYA or LOPE: Which Is the Better Value Stock Right Now?